Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-128,036
Closed -$1.24M 388
2025
Q2
$1.24M Buy
128,036
+7,898
+7% +$88.8K ﹤0.01% 850
2025
Q1
$1.53M Hold
120,138
0.01% 786
2024
Q4
$2.48M Sell
120,138
-7,457
-6% -$122K 0.01% 711
2024
Q3
$1.8M Hold
127,595
0.01% 769
2024
Q2
$1.59M Buy
+127,595
New +$1.55M ﹤0.01% 811
2023
Q4
Sell
-115,499
Closed -$1.74M 1086
2023
Q3
$1.74M Buy
+115,499
New +$2.17M 0.01% 735
2022
Q3
Sell
-30,570
Closed -$774K 1158
2022
Q2
$774K Buy
+30,570
New +$881K ﹤0.01% 913

Other funds holding EMBC

Axa's EMBC Position: Q3 2025 in Review

Axa sold out of Embecta (EMBC) in Q3 2025, closing a stake of 128,036 shares — an estimated $1.24M sold.

Axa first reported a position in EMBC in Q2 2022 and held it in 7 quarters. The position peaked at $2.48M in Q4 2024. 353 funds tracked by Wall St. Rank hold EMBC as of Q3 2025.

  • Axa reported no remaining Embecta position as of Q3 2025 after selling out during the quarter.
  • Axa sold 128,036 Embecta shares in Q3 2025, an estimated $1.24M.
  • Axa first reported a position in Embecta in Q2 2022 and held it in 7 quarters.
  • Axa's Embecta position peaked at $2.48M in Q4 2024.
  • 353 funds tracked by Wall St. Rank held Embecta as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.